{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:17:55Z","timestamp":1774055875976,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bmc.2019.05.014","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T01:38:45Z","timestamp":1557711525000},"page":"2857-2870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni"],"prefix":"10.1016","volume":"27","author":[{"given":"D.J.","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Van de Langemheen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Koehne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kreidenweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.J.","family":"Liskamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bmc.2019.05.014_b0005","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov Today"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0010","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/0929867323666160318173706","article-title":"Immunoproteasome-Selective Inhibitors: A Promising Strategy to Treat Hematologic Malignancies, Autoimmune and Inflammatory Diseases","volume":"23","author":"Ettari","year":"2016","journal-title":"Curr Med Chem"},{"issue":"36","key":"10.1016\/j.bmc.2019.05.014_b0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1021\/cen-v089n036.p019","article-title":"Covalent drugs form long-lived ties","volume":"89","author":"Guterman","year":"2011","journal-title":"Chem Eng News"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0020","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1021\/cr010182v","article-title":"Irreversible inhibitors of serine, cysteine, and threonine proteases","volume":"102","author":"Powers","year":"2002","journal-title":"Chem Rev"},{"issue":"26","key":"10.1016\/j.bmc.2019.05.014_b0025","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1016\/j.tetlet.2009.02.130","article-title":"Synthesis of \u03b2-aminoethanesulfonyl fluorides or 2-substituted taurine sulfonyl fluorides as potential protease inhibitors","volume":"50","author":"Brouwer","year":"2009","journal-title":"Tetrahedron Lett"},{"issue":"24","key":"10.1016\/j.bmc.2019.05.014_b0030","doi-asserted-by":"crossref","first-page":"10995","DOI":"10.1021\/jm301443r","article-title":"Peptido sulfonyl fluorides as new powerful proteasome inhibitors","volume":"55","author":"Brouwer","year":"2012","journal-title":"J Med Chem"},{"issue":"44","key":"10.1016\/j.bmc.2019.05.014_b0035","doi-asserted-by":"crossref","first-page":"11969","DOI":"10.1002\/anie.201406964","article-title":"Selective inhibition of the immunoproteasome by ligand-induced crosslinking of the active site","volume":"53","author":"Dubiella","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0040","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1021\/acs.jmedchem.8b00685","article-title":"Potent and highly selective inhibitors of the proteasome trypsin-like site by incorporation of basic side chain containing amino acid derived sulfonyl fluorides","volume":"61","author":"Artschwager","year":"2018","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2019.05.014_b0045","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.chembiol.2018.04.013","article-title":"Targeted covalent inhibition of prolyl oligopeptidase (POP): discovery of sulfonylfluoride peptidomimetics","volume":"25","author":"Guardiola","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"4","key":"10.1016\/j.bmc.2019.05.014_b0050","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/jm901633v","article-title":"Nonpeptidic Tetrafluorophenoxymethyl Ketone Cruzain Inhibitors as Promising New Leads for Chagas Disease Chemotherapy","volume":"53","author":"Brak","year":"2010","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.bmc.2019.05.014_b0055","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.bmcl.2006.02.026","article-title":"Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents","volume":"16","author":"Vicik","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"46","key":"10.1016\/j.bmc.2019.05.014_b0060","doi-asserted-by":"crossref","first-page":"11351","DOI":"10.1021\/ja972204u","article-title":"Structure and design of potent and selective cathepsin k inhibitors","volume":"119","author":"Yamashita","year":"1997","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/jm901069a","article-title":"Identification and Optimization of Inhibitors of Trypanosomal Cysteine Proteases: Cruzain, Rhodesain, and TbCatB","volume":"53","author":"Mott","year":"2010","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acsmedchemlett.6b00276","article-title":"Dipeptidyl Nitroalkenes as Potent Reversible Inhibitors of Cysteine Proteases Rhodesain and Cruzain","volume":"7","author":"Latorre","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"14","key":"10.1016\/j.bmc.2019.05.014_b0075","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0960-894X(95)00236-M","article-title":"Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L","volume":"5","author":"Woo","year":"1995","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"10.1016\/j.bmc.2019.05.014_b0080","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/jm010459j","article-title":"Synthesis and Structure\u2212Activity Relationship Study of Potent Trypanocidal Thio Semicarbazone Inhibitors of the Trypanosomal Cysteine Protease Cruzain","volume":"45","author":"Du","year":"2002","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.bmc.2019.05.014_b0085","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1021\/jm900629w","article-title":"On-Bead Screening of a Combinatorial Fumaric Acid Derived Peptide Library Yields Antiplasmodial Cysteine Protease Inhibitors with Unusual Peptide Sequences","volume":"52","author":"Machon","year":"2009","journal-title":"J Med Chem"},{"issue":"22","key":"10.1016\/j.bmc.2019.05.014_b0090","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1021\/jm00074a031","article-title":"Peptide.alpha.-keto ester,alpha.-keto amide, and.alpha.-keto acid inhibitors of calpains and other cysteine proteases","volume":"36","author":"Li","year":"1993","journal-title":"J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2019.05.014_b0095","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1021\/jm00017a002","article-title":"Vinyl sulfones as mechanism-based cysteine protease inhibitors","volume":"38","author":"Palmer","year":"1995","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bmc.2019.05.014_b0100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1271\/bbb.60.1439","article-title":"S-methyl methanethiosulfonate, bio-antimutagen in homogenates of cruciferae and liliaceae vegetables","volume":"60","author":"Nakamura","year":"1996","journal-title":"Biosci Biotechnol Biochem"},{"issue":"8","key":"10.1016\/j.bmc.2019.05.014_b0105","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/carcin\/20.8.1645","article-title":"Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion\/progression stages of colon carcinogenesis","volume":"20","author":"Reddy","year":"1999","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.bmc.2019.05.014_b0110","doi-asserted-by":"crossref","first-page":"25891","DOI":"10.1074\/jbc.M313853200","article-title":"New Insights into Protein S -Nitrosylation","volume":"279","author":"Foster","year":"2004","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35055104","article-title":"Protein S-nitrosylation: a physiological signal for neuronal nitric oxide","volume":"3","author":"Jaffrey","year":"2001","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.bmc.2019.05.014_b0120","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-2836(02)00809-4","article-title":"Structure and Inactivation of Triosephosphate Isomerase from Entamoeba histolytica","volume":"322","author":"Rodr\u0131\u0301guez-Romero","year":"2002","journal-title":"J Mol Biol"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0125","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/abbi.1998.0757","article-title":"Human betaine-homocysteine methyltransferase is a zinc metalloenzyme","volume":"356","author":"Millian","year":"1998","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0130","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1073\/pnas.97.12.6463","article-title":"Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase","volume":"97","author":"Lowther","year":"2000","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"10.1016\/j.bmc.2019.05.014_b0135","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1002\/1521-3765(20020916)8:18<4129::AID-CHEM4129>3.0.CO;2-V","article-title":"Chemically modified \u201cpolar patch\u201d mutants of subtilisin in peptide synthesis with remarkably broad substrate acceptance: designing combinatorial biocatalysts","volume":"8","author":"Matsumoto","year":"2002","journal-title":"Chem Eur J"},{"key":"10.1016\/j.bmc.2019.05.014_b0140","series-title":"Cysteine Proteases of Pathogenic Organisms","first-page":"100","author":"Sajid","year":"2011"},{"issue":"8","key":"10.1016\/j.bmc.2019.05.014_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005840","article-title":"Cysteine proteases as digestive enzymes in parasitic helminths","volume":"12","author":"Caffrey","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0150","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0160","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02174045","article-title":"Small synthetic inhibitors of cysteine proteases","volume":"6","author":"Rasnick","year":"1996","journal-title":"Perspect Drug Discov Des"},{"issue":"41","key":"10.1016\/j.bmc.2019.05.014_b0165","doi-asserted-by":"crossref","first-page":"35770","DOI":"10.1074\/jbc.M111.271304","article-title":"Structural basis for inhibition of cathepsin b drug target from the human blood fluke, schistosoma mansoni","volume":"286","author":"J\u00edlkov\u00e1","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1515\/bchm.1998.379.2.137","article-title":"Revised definition of substrate binding sites of papain-like cysteine proteases","volume":"379","author":"Turk","year":"1998","journal-title":"Biol Chem"},{"issue":"03","key":"10.1016\/j.bmc.2019.05.014_b0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2002-20031","article-title":"New and Facile Synthesis of Thiosulfonates from Sulfinate\/Disulfide\/I2 System","volume":"2002","author":"Fujiki","year":"2002","journal-title":"Synthesis (Stuttg)"},{"issue":"24","key":"10.1016\/j.bmc.2019.05.014_b0180","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1055\/s-2006-950353","article-title":"Sulfonyl chloride formation from thiol derivatives by N -chlorosuccinimide mediated oxidation","volume":"2006","author":"Nishiguchi","year":"2006","journal-title":"Synthesis (Stuttg)"},{"issue":"3","key":"10.1016\/j.bmc.2019.05.014_b0185","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/acs.orglett.5b03535","article-title":"Total synthesis of K777: successful application of transition-metal-catalyzed alkyne hydrothiolation toward the modular synthesis of a potent cysteine protease inhibitor","volume":"18","author":"Kiemele","year":"2016","journal-title":"Org Lett"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0074-02762009000900034","article-title":"Two approaches to discovering and developing new drugs for Chagas disease","volume":"104","author":"Mckerrow","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"sup1","key":"10.1016\/j.bmc.2019.05.014_b0195","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1517\/17460441.2.S1.S35","article-title":"Praziquantel resistance","volume":"2","author":"Botros","year":"2007","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"10.1016\/j.bmc.2019.05.014_b0200","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.1999.60.932","article-title":"Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers","volume":"60","author":"William","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-6851(97)00098-4","article-title":"Proteolytic degradation of host hemoglobin by schistosomes","volume":"89","author":"Brindley","year":"1997","journal-title":"Mol Biochem Parasitol"},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0014-4894(79)90098-5","article-title":"Schistosoma mansoni: thiol proteinase properties of adult worm \u201chemoglobinase\u201d","volume":"48","author":"Dresden","year":"1979","journal-title":"Exp Parasitol"},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0166-6851(96)02703-X","article-title":"Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo","volume":"81","author":"Wasilewski","year":"1996","journal-title":"Mol Biochem Parasitol"},{"issue":"12","key":"10.1016\/j.bmc.2019.05.014_b0220","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1021\/cr0101656","article-title":"Human and parasitic Papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design","volume":"102","author":"Lecaille","year":"2002","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.bmc.2019.05.014_b0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1371\/journal.pmed.0040014","article-title":"Schistosomiasis mansoni: novel chemotherapy using a cysteine protease inhibitor. Krishna S, ed.","volume":"4","author":"Abdulla","year":"2007","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.bmc.2019.05.014_b0230","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.03809-14","article-title":"Lactate as a novel quantitative measure of viability in schistosoma mansoni drug sensitivity assays","volume":"59","author":"Howe","year":"2015","journal-title":"Antimicrob Agents Chemother."},{"issue":"21","key":"10.1016\/j.bmc.2019.05.014_b0235","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1021\/jo971176v","article-title":"NMR chemical shifts of common laboratory solvents as trace impurities","volume":"62","author":"Gottlieb","year":"1997","journal-title":"J Org Chem"},{"issue":"7","key":"10.1016\/j.bmc.2019.05.014_b0240","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.bmc.2011.02.014","article-title":"Synthesis and biological evaluation of novel irreversible serine protease inhibitors using amino acid based sulfonyl fluorides as an electrophilic trap","volume":"19","author":"Brouwer","year":"2011","journal-title":"Bioorg Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619304171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089619304171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:01:48Z","timestamp":1760835708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089619304171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":48,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0968089619304171"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2019.05.014","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly tunable thiosulfonates as a novel class of cysteine protease inhibitors with anti-parasitic activity against Schistosoma mansoni","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2019.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}